NCT04806646View on ClinicalTrials.gov

Tailored Sonidegib Schedule After Complete Response in BCC

PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2026

Conditions
Locally Advanced Basal Cell Carcinoma
Interventions
DRUG

Sonidegib

TS1: assumption 14 days on and 14 days off. TS2: assumption 7 days on and 21 days off.

Trial Locations (1)

Unknown

RECRUITING

Asst Degli Spedali Civili Di Brescia, Brescia

All Listed Sponsors
lead

Gruppo Oncologico del Nord-Ovest

OTHER